MedTrace Logo

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

NCT00002887 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-09-17

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug is a way to kill more tumor cells.

PURPOSE: Phase I trial to study the effects of hydroxyurea plus combination chemotherapy in patients with non-small cell lung cancer.

Conditions

Interventions

DRUG

cisplatin

DRUG

etoposide

DRUG

hydroxyurea

DRUG

vinblastine sulfate

DRUG

vindesine

DRUG

vinorelbine tartrate

PROCEDURE

drug resistance inhibition treatment

Sponsors & Collaborators

  • Ottawa Regional Cancer Centre

    lead OTHER

Principal Investigators

  • David J. Stewart, MD, FRCPC · Ottawa Regional Cancer Centre

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002887 on ClinicalTrials.gov